Faecal microbiota transplantation and the patient experience: A systematic review

Jessica Guilfoyle1, Julie Considine1,2,3, Stéphane L Bouchoucha1,2

  • 1School of Nursing and Midwifery, Deakin University, Geelong, Vic., Australia.

Journal of Clinical Nursing
|December 30, 2020
PubMed
Abstract

Insights

Patients undergoing fecal microbiota transplantation (FMT) report diverse experiences, finding the procedure unpleasant despite not deeming it unappealing. Further research is needed to understand patient perspectives for improved care.

Area of Science:

  • Gastroenterology
  • Microbiome Research
  • Patient Experience Studies

Background:

  • Fecal microbiota transplantation (FMT) is a recognized treatment for conditions like Clostridium Difficile infections.
  • Understanding patient experience is crucial for treatment adherence and clinical decision-making.

Purpose of the Study:

  • To systematically review and synthesize existing literature on patients' experiences with fecal microbiota transplantation.
  • To identify key themes and factors influencing patient perspectives on FMT.

Main Methods:

  • A systematic literature search was conducted across CINAHL, Medline, and Embase databases up to June 2020.
  • PRISMA guidelines were followed, with quality appraisal using CASP tools by three independent reviewers.
  • Narrative synthesis was employed to analyze data from 12 included studies.

Main Results:

  • The review identified 12 studies of moderate to low methodological quality.
  • Few studies focused solely on patient experience; most emphasized clinical outcomes or hypothetical scenarios.
  • Patient experiences were complex, encompassing physiological and psychological aspects influenced by medical condition, administration method, and efficacy.

Conclusions:

  • Patients generally did not find FMT unappealing but reported the procedure itself as unpleasant.
  • Limited and low-quality evidence highlights the need for further research into patient experiences with FMT.
  • Understanding patient perspectives can inform alternative therapies and enhance care quality for FMT recipients.